Anti-hyperactivity medication: methylphenidate and amphetamine

被引:190
作者
Seeman, P
Madras, BK
机构
[1] Univ Toronto, Dept Pharmacol, Toronto, ON M5S 1A8, Canada
[2] Univ Toronto, Dept Psychiat, Toronto, ON M5S 1A8, Canada
[3] Harvard Univ, New England Reg Primate Res Ctr, Sch Med, Dept Psychiat,Div Neurochem, Southborough, MA 01772 USA
关键词
hyperactivity; attention deficit; methylphenidate; amphetamine; dopamine;
D O I
10.1038/sj.mp.4000421
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
How do 'stimulants' reduce hyperactivity in children and adults? How can drugs which raise extracellular dopamine result in psychomotor slowing of hyperactive children when dopamine is known to enhance motor activity, such as in Parkinson's disease? These apparent paradoxes are the focus of this brief review on the mechanism of action of stimulant medications used in the treatment of children, and of an increasing number of adults who meet diagnostic criteria for attention deficit hyperactivity disorder.
引用
收藏
页码:386 / 396
页数:11
相关论文
共 105 条
[31]   NONLINEAR RELATIONSHIP BETWEEN IMPULSE FLOW AND DOPAMINE RELEASED BY RAT MIDBRAIN DOPAMINERGIC-NEURONS AS STUDIED BY INVIVO ELECTROCHEMISTRY [J].
GONON, FG .
NEUROSCIENCE, 1988, 24 (01) :19-28
[32]  
GRANDY DK, 1989, AM J HUM GENET, V45, P778
[33]   L-DOPA REVERSES THE ELEVATED DENSITY OF D-2 DOPAMINE-RECEPTORS IN PARKINSONS DISEASED STRIATUM [J].
GUTTMAN, M ;
SEEMAN, P .
JOURNAL OF NEURAL TRANSMISSION, 1985, 64 (02) :93-103
[34]   AMPHETAMINE-INDUCED HYPOLOCOMOTION IN MICE WITH MORE BRAIN-D2 DOPAMINE-RECEPTORS [J].
HELMESTE, DM ;
SEEMAN, P .
PSYCHIATRY RESEARCH, 1982, 7 (03) :351-359
[35]   A CAUTIONARY GENETIC TALE - THE SOBERING STORY OF D-2 [J].
HOLDEN, C .
SCIENCE, 1994, 264 (5166) :1696-1697
[36]   ADDITIVE EFFECTS OF PSYCHOSTIMULANTS, PARENT TRAINING, AND SELF-CONTROL THERAPY WITH ADHD CHILDREN [J].
HORN, WF ;
IALONGO, NS ;
PASCOE, JM ;
GREENBERG, G ;
PACKARD, T ;
LOPEZ, M ;
WAGNER, A ;
PUTTLER, L .
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1991, 30 (02) :233-240
[37]  
HORNYKIEWICZ O, 1966, PHARMACOL REV, V18, P925
[38]   ACUTE AND CHRONIC AMPHETAMINE TREATMENTS MODULATE STRIATAL DOPAMINE RECEPTOR-BINDING SITES [J].
HOWLETT, DR ;
NAHORSKI, SR .
BRAIN RESEARCH, 1979, 161 (01) :173-178
[39]   INVIVO NEUROCHEMICAL PROFILE OF DOPAMINE UPTAKE INHIBITORS AND RELEASERS IN RAT CAUDATE-PUTAMEN [J].
HURD, YL ;
UNGERSTEDT, U .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 166 (02) :251-260
[40]   CHRONIC COCAINE ALTERS LIMBIC EXTRACELLULAR DOPAMINE - NEUROCHEMICAL BASIS FOR ADDICTION [J].
IMPERATO, A ;
MELE, A ;
SCROCCO, MG ;
PUGLISIALLEGRA, S .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 212 (2-3) :299-300